A decade post WHI, menopausal hormone therapy comes full circle - Need for independent commission

Climacteric

Volumn 15, Issue 4, 2012, Pages 320-325

  Utian, W H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ESTROGEN AND PROGESTOGEN THERAPY; ESTROGEN THERAPY; MENOPAUSAL HORMONE THERAPY; WOMEN'S HEALTH; WOMEN'S HEALTH INITIATIVE

Indexed keywords

ESTROGEN; GESTAGEN; PLACEBO;

BREAST CANCER; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG FATALITY; DRUG SAFETY; ESTROGEN THERAPY; FEMALE; FOOD AND DRUG ADMINISTRATION; FRACTURE; HEALTH CARE ORGANIZATION; HEART PROTECTION; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MEDICAL SOCIETY; MENOPAUSAL SYNDROME; OSTEOPOROSIS; POSTMENOPAUSAL HORMONE THERAPY; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; STROKE; WOMEN'S HEALTH;

ADULT; ADVISORY COMMITTEES; AGE FACTORS; AGED; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; FEMALE; HIP FRACTURES; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); OSTEOPOROSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84863591423     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2012.678916     Document Type: Review

References (19)

1. NIH News Release: nhlbi stops trial of estrogen plus progestin due to increased breast cancer risk, lack of overall benefi t. NHLBI Communications Offi ce, Tuesday, July 9, 2002
2. Rossouw JE, Anderson GL, Prentice RL, et al. for the Women's Health Initiative Investigators. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
3. Utian WH. Managing menopause after HERS II and WHI: Coping with the aftermath. Menopause Management 2002;11:6-7
4. Utian WH. Personal perspective. NIH and WHI - time for a mea culpa and steps beyond. Menopause 2007;14:1056-9
5. Utian WH. Thoughts on suffering and dying - or, is disease A really equivalent to disease B Menopause Management 2004;13:9-10
6. Anderson GL, Judd HL, Kaunitz AM, e t al. for the WHI Investigators. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures. JAMA 2003;290:1739-48
7. Anderson GL, Judd HL, Kaunitz AM, e t a l. Hormone therapy and risk of gynecologic cancer. JAMA 2004;29:43
8. Shumaker S, Legault C, Rapp S, et al . Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: THE Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 2003;289:2651-62
9. Rossouw JE, Prentice RL, Manson JE, et a l. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77
10. Manson JE, Allison MA, Rossouw JE, e t a l. Estrogen therapy and coronary artery calcifi cation. N Engl J Med 2007;356:2591-602
11. Hodis HN. Commentary on the WHI Coronary-Artery Calcium Study of Manson, et al. (ref 5). North American Menopause Society First to Know electronic newsletter, 2007 (June):2-4
12. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogens in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12
13. Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN. Hip fracture in postmenopausal women after cessation of hormone therapy: Results from a large health management organization. Menopause 2011;18:1172-7
14. The North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2012 position statement of The North American Menopause Society. Menopause 2012; 19:257-71
15. Parker-Pope T. How NIH misread hormone study in 2002. Wall Street J July 9, 2007:B1
16. Rossouw JE, Stefanick ML. We stand by data on heart disease risk in estrogen drug study. Wall Street J July 21 2007:A5
17. Utian WH. Hormone therapy and risk of gynecologic cancers. JAMA 2004;291:42-3
18. Anderson G, LaCroix A, Limacher M, et al . WHI Investigators letter to the editor. Menopause 2012;19. Epub ahead of print. Accessed June 8, 2012. DOI: 10.1097/gme.0b013e3182594f76
19. Gass M, Manson J, Stuenkel C, et a l . Response to WHI Investigators' letter to the editor 2012 - 03-13. Menopause 2012;19. Epub ahead of print. Accessed June 8, 2012. DOI: 10.1097/gme. 0b013e31825b32ea.